Design of a novel chimeric peptide via dual blockade of CD47/SIRPα and PD-1/PD-L1 for cancer immunotherapy.
Hu Z, Li W, Chen S, Chen D, Xu R, Zheng D, Yang X, Li S, Zhou X, Niu X, Xiao Y, He Z, Li H, Liu J, Sui X, Gao Y.
Hu Z, et al. Among authors: gao y.
Sci China Life Sci. 2023 Oct;66(10):2310-2328. doi: 10.1007/s11427-022-2285-6. Epub 2023 Apr 21.
Sci China Life Sci. 2023.
PMID: 37115491